NCT06657105View on ClinicalTrials.gov

A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

February 3, 2025

Study Completion Date

February 3, 2025

Conditions
Healthy Participants
Interventions
DRUG

EE/LNG

EE/LNG tablet will be administered orally.

DRUG

Baxdrostat

Baxdrostat tablet will be administered orally.

Trial Locations (1)

21225

Research Site, Brooklyn

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT06657105 - A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential | Biotech Hunter | Biotech Hunter